PD-L1 PET/CT imaging shows partial tumor saturation during atezolizumab treatment

被引：0
|
作者：
Smit, L. M. [1 ]
Hooiveld, J. [1 ]
van de Donk, P. P. [1 ]
de Ruijter, L. Kist [1 ]
Kok, I. C. [1 ]
Winkel, C. A. J. [1 ]
Giesen, D. [2 ]
Lub-de Hooge, M. N. [3 ]
Brouwers, A. H. [2 ]
Oosting, S. F. [4 ]
Bensch, F. [5 ]
Schroder, C. P. [1 ]
Jalving, M. [1 ]
Elias, S. G. [6 ]
Gietema, J. A. [1 ]
Deurloo, R. J. [7 ]
Williams, S. P. [8 ]
Ungewickell, A. [9 ]
De Groot, D. J. A. [1 ]
de Vries, E. G. E. [1 ]
机构：
[1] Univ Med Ctr Groningen, Med Oncol, Groningen, Netherlands
[2] Univ Med Ctr Groningen, Nucl Med & Mol Imaging, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Clin Pharm & Pharmacol, Groningen, Netherlands
[4] Univ Med Ctr Groningen, Med Oncol, Groningen, Netherlands
[5] Univ Med Ctr Groningen, Pulm Dis, Groningen, Netherlands
[6] Univ Med Ctr Utrecht, Epidemiol & Hlth Econ, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[7] F Hoffmann La Roche Ltd, Translat Med Oncol, Basel, Switzerland
[8] Genentech Inc, Biomed Imaging Res Biol, San Francisco, CA USA
[9] Genentech Inc, Clin Dev Hematol Oncol, San Francisco, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114777
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB248
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [21] Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics
    Yang, Hongzhang
    Zeng, Xinying
    Liu, Jia
    Wen, Xuejun
    Liu, Huanhuan
    Liang, Yuanyuan
    Wang, Xueqi
    Fang, Jianyang
    Zhang, Qinglin
    Li, Jindian
    Zhang, Xianzhong
    Guo, Zhide
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (06) : 1582 - 1592
  • [22] Relevance of host and tumor PD-L1 in PD-L1 pathway blockade
    Kryczek, Ilona
    Lin, Heng
    Wei, Shuang
    Green, Michael
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [23] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [24] PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody
    Lv, Gaochao
    Sun, Xiaorong
    Qiu, Ling
    Sun, Yan
    Li, Ke
    Liu, Qingzhu
    Zhao, Qi
    Qin, Songbing
    Lin, Jianguo
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) : 117 - 122
  • [25] Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma
    Sharma, Gitanjali
    Braga, Marta C.
    Da Pieve, Chiara
    Szopa, Wojciech
    Starzetz, Tatjana
    Plate, Karl H.
    Kaspera, Wojciech
    Kramer-Marek, Gabriela
    CANCERS, 2023, 15 (12)
  • [26] PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer
    Heskamp, Sandra
    Wierstra, Peter J.
    Molkenboer-Kuenen, Janneke D. M.
    Sandker, Gerwin W.
    Thordardottir, Soley
    Cany, Jeannette
    Olive, Daniel
    Bussink, Johan
    Boerman, Otto C.
    Dolstra, Harry
    Aarntzen, Erik H. J. G.
    Hobo, Willemijn A.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (01) : 150 - 161
  • [27] PD-L1 microSPECT/CT imaging for longitudinal monitoring of PD-L1 expression in syngeneic and humanized mouse models for cancer
    Heskamp, S.
    Verhoeff, S. R.
    Wierstra, P. J.
    Molkenboer-Kuenen, J. D. M.
    Sandker, G. W.
    Thordardottir, S.
    Olive, D.
    Bussink, J.
    Boerman, O. C.
    Dolstra, H.
    Aarntzen, E. H. J. G.
    Hobo, W. A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [28] Venetoclax, Obinutuzumab and Atezolizumab (PD-L1 Checkpoint Inhibitor) for Treatment for Patients with Richter Transformation
    Jain, Nitin
    Ferrajoli, Alessandra
    Thompson, Philip A.
    Konopleva, Marina
    Green, Michael R.
    Sampath, Deepa
    Neelapu, Sattva S.
    Takahashi, Koichi
    Strati, Paolo
    Burger, Jan A.
    Kanagal-Shamanna, Rashmi
    Khoury, Joseph D.
    Garg, Naveen
    Su, Xiaoping
    Wang, Xuemei
    Patel, Hinalben
    Ayala, Ana
    Kantarjian, Hagop
    Keating, Michael J.
    Wierda, William G.
    BLOOD, 2021, 138
  • [29] PET imaging of radiation-induced PD-L1 upregulation in the tumor microenvironment using a Zr-89 labeled PD-L1 monoclonal Ab in a mouse model
    Kikuchi, Masahiro
    Srivastava, Raghvendra
    Sun, Lingyi
    Zeng, Dexing
    Diaz-Perez, Julio
    Anderson, Carolyn
    Ferris, Robert
    Edwards, W. Barry
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [30] Efficacy and Safety of Atezolizumab as a PD-L1 Inhibitor in the Treatment of Cervical Cancer: A Systematic Review
    Velimirovici, Milan Daniel
    Feier, Catalin Vladut Ionut
    Vonica, Razvan Constantin
    Faur, Alaviana Monique
    Muntean, Calin
    BIOMEDICINES, 2024, 12 (06)
12345